HIPPO HOLDINGS INC (HIPO) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIPO - US4335392027 - Common Stock
31.59 USD
+0.07 (+0.22%)
31.59 USD
0 (0%)
Taking everything into account, HIPO scores 4 out of 10 in our fundamental rating. HIPO was compared to 148 industry peers in the Insurance industry. HIPO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HIPO is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
HIPO had positive earnings in the past year.
HIPO had a negative operating cash flow in the past year.
In the past 5 years HIPO always reported negative net income.
HIPO had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
HIPO has a better Return On Assets (5.12%) than 82.43% of its industry peers.
HIPO has a Return On Equity of 22.75%. This is amongst the best in the industry. HIPO outperforms 89.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 22.75% | ||
| ROIC | N/A |
ROA(3y)-13.93%
ROA(5y)-15.77%
ROE(3y)-46.66%
ROE(5y)-56.13%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 21.31%, HIPO belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
HIPO does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 21.31% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HIPO has more shares outstanding
Compared to 5 years ago, HIPO has more shares outstanding
HIPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIPO has an Altman-Z score of -0.34. This is a bad value and indicates that HIPO is not financially healthy and even has some risk of bankruptcy.
HIPO's Altman-Z score of -0.34 is fine compared to the rest of the industry. HIPO outperforms 66.22% of its industry peers.
HIPO has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.11, HIPO is doing good in the industry, outperforming 76.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.34 |
ROIC/WACCN/A
WACC8.83%
2.3 Liquidity
A Current Ratio of 3.79 indicates that HIPO has no problem at all paying its short term obligations.
HIPO has a better Current ratio (3.79) than 93.92% of its industry peers.
A Quick Ratio of 3.79 indicates that HIPO has no problem at all paying its short term obligations.
HIPO's Quick ratio of 3.79 is amongst the best of the industry. HIPO outperforms 93.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 165.70% over the past year.
Looking at the last year, HIPO shows a very strong growth in Revenue. The Revenue has grown by 34.48%.
HIPO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.72% yearly.
EPS 1Y (TTM)165.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%662.69%
Revenue 1Y (TTM)34.48%
Revenue growth 3Y59.79%
Revenue growth 5Y60.72%
Sales Q2Q%26.28%
3.2 Future
The Earnings Per Share is expected to grow by 44.34% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.11% on average over the next years. This is quite good.
EPS Next Y203.31%
EPS Next 2Y41.48%
EPS Next 3Y32.25%
EPS Next 5Y44.34%
Revenue Next Year27.75%
Revenue Next 2Y22.71%
Revenue Next 3Y21.28%
Revenue Next 5Y19.11%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.73, which indicates a very decent valuation of HIPO.
Based on the Price/Earnings ratio, HIPO is valued a bit cheaper than the industry average as 70.95% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.00. HIPO is valued rather cheaply when compared to this.
HIPO is valuated quite expensively with a Price/Forward Earnings ratio of 9300.48.
Based on the Price/Forward Earnings ratio, HIPO is valued expensively inside the industry as 82.43% of the companies are valued cheaper.
HIPO is valuated expensively when we compare the Price/Forward Earnings ratio to 23.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.73 | ||
| Fwd PE | 9300.48 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HIPO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HIPO's earnings are expected to grow with 32.25% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y41.48%
EPS Next 3Y32.25%
5. Dividend
5.1 Amount
HIPO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
31.59
+0.07 (+0.22%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners49.88%
Inst Owner Change0%
Ins Owners9.05%
Ins Owner Change-0.57%
Market Cap800.49M
Revenue(TTM)450.10M
Net Income(TTM)95.90M
Analysts80
Price Target40.46 (28.08%)
Short Float %2.42%
Short Ratio2.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.4%
Min EPS beat(2)89.54%
Max EPS beat(2)107.26%
EPS beat(4)3
Avg EPS beat(4)215.38%
Min EPS beat(4)-18.4%
Max EPS beat(4)683.12%
EPS beat(8)6
Avg EPS beat(8)113.05%
EPS beat(12)7
Avg EPS beat(12)69.89%
EPS beat(16)7
Avg EPS beat(16)40.05%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)1.08%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.53%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)3.95%
Revenue beat(12)8
Avg Revenue beat(12)4.79%
Revenue beat(16)9
Avg Revenue beat(16)3.48%
PT rev (1m)-1.65%
PT rev (3m)7.21%
EPS NQ rev (1m)20%
EPS NQ rev (3m)277.78%
EPS NY rev (1m)2012.51%
EPS NY rev (3m)95.34%
Revenue NQ rev (1m)-0.91%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.73 | ||
| Fwd PE | 9300.48 | ||
| P/S | 1.78 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.9 | ||
| P/tB | 2.2 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.62
EY11.46%
EPS(NY)0
Fwd EY0.01%
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS17.76
BVpS16.63
TBVpS14.37
PEG (NY)0.04
PEG (5Y)N/A
Graham Number36.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 22.75% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 21.31% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-13.93%
ROA(5y)-15.77%
ROE(3y)-46.66%
ROE(5y)-56.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 48.28% | ||
| Cap/Sales | 2.49% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.79 | ||
| Altman-Z | -0.34 |
F-Score6
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)139.06%
Cap/Depr(5y)143.13%
Cap/Sales(3y)13.98%
Cap/Sales(5y)15.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)165.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%662.69%
EPS Next Y203.31%
EPS Next 2Y41.48%
EPS Next 3Y32.25%
EPS Next 5Y44.34%
Revenue 1Y (TTM)34.48%
Revenue growth 3Y59.79%
Revenue growth 5Y60.72%
Sales Q2Q%26.28%
Revenue Next Year27.75%
Revenue Next 2Y22.71%
Revenue Next 3Y21.28%
Revenue Next 5Y19.11%
EBIT growth 1Y72.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.62%
EBIT Next 3Y33.9%
EBIT Next 5Y28.14%
FCF growth 1Y90.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.46%
OCF growth 3YN/A
OCF growth 5YN/A
HIPPO HOLDINGS INC / HIPO FAQ
What is the fundamental rating for HIPO stock?
ChartMill assigns a fundamental rating of 4 / 10 to HIPO.
What is the valuation status for HIPO stock?
ChartMill assigns a valuation rating of 4 / 10 to HIPPO HOLDINGS INC (HIPO). This can be considered as Fairly Valued.
Can you provide the profitability details for HIPPO HOLDINGS INC?
HIPPO HOLDINGS INC (HIPO) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for HIPO stock?
The Earnings per Share (EPS) of HIPPO HOLDINGS INC (HIPO) is expected to grow by 203.31% in the next year.